2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Thursday, June 8, 2017

1:15pm-2:45pm: Prevalence of Babinski-2 sign in Hemifacial Spasm Patients

O. Dogu, H. Kalegasi (Mersin, Turkey)

Other · Exhibit Hall C

1:15pm-2:45pm: Prevelance,clinical pathology and Treatment of Dystonia in Pakistani Population

S. Naureen, A. Arshad, N. Ahmad (RAWALPINDI, Pakistan)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: Preventing Levodopa Induced Dyskinesia with Docosohexanoid Acid in Parkinson Disease

K. Chung, B. Lobb (Portland, OR, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Prognosis and end-of-life status after emergency admissions in patients with Parkinson disease: a Japanese single center retrospective study

K. Ikeda, K. Takahashi, K. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Araki, T. Yamamoto (Iruma-gun, Saitama-ken, Japan)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Programming of deep brain stimulators in Parkinson’s disease with early motor complications (EARLYSTIM-study)

K. Knudsen, J.-L. Houeto, P. Krack, J. Rau, C. Schade-Brittinger, A. Schnitzler, W.M.M. Schuepbach, L. Timmermann, L. Tonder, G. Deuschl (Kiel, Germany)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events

M. Schuberth, J. Levin, S. Maaß, G. Respondek, K. Bötzel, G. Höglinger (Muenchen, Germany)

Clinical Trials and Therapy in Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Proprioceptive Focal Stimulation (Equistasi®) may improve gait in severe Parkinson’s disease patients. Gait Analysis double-blind, double-dummy randomized study

A. Peppe, S. Paravati, g. Chini, P. Paone (Roma, Italy)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Prospective Analysis of Morphological Markers of Development of Impulsive Compulsive Behaviors in De Novo Parkinson’s Disease

L. Ricciardi, C. Lambert, R. De Micco, F. Morgante, M. Edwards (London, United Kingdom)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Quantitative demonstration of the efficacy of rotigotine transdermal patch in the treatment of nocturnal hypokinesia: A randomized, placebo-controlled trial using an axial inertial sensor

R. Bhidayasiri, J. Sringean, S. Chaiwong, C. Anan, K. Boonpang, K. Sakdisornchai, O. Jitkritsadakul, P. Jagota (Bangkok, Thailand)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: RAB12 variants and their role in dystonia

K. Lohmann, E. Hebert, F. Borngräber, A. Schmidt, A. Rakovic, A. Weissbach, J. Hampf, E.-J. Vollstedt, S. Schaake, H. Manzoor, H.-C. Jabusch, M. Kasten, V. Kostic, T. Gasser, K. Zeuner, P. Bauer, E. Altenmüller, C. Klein (Luebeck, Germany)

Dystonia · Exhibit Hall C